1. Andrews, B. E; Moore, N. (ed.) (2014) Mann’s Pharmacovigilance. 3rd ed. West Sussex, UK: Wiley Blackwell, ha. 1-354. https://doi.org/10.1002/9781118820186
2. Athira, B., Cs, M. and Jyothi, E. (2015) “A study on adverse drug reactions to first-line antitubercular drugs in DOTS therapy,” International Journal of Pharmacology and Clinical Sciences March, 4(1), p. 7–11
3. Badan POM RI (2017a) “Profil Laporan Efek Samping Obat Tahun 2016 (1),” Buletin Berita MESO. 35 No. 1, hal. 7–8. doi: ISSN: 08526184
4. Badan POM RI (2017b) e-meso.pom.go.id. Tersedia pada: e-meso.pom.go.id
5. Böhm, R. (2015) “Primer on Disproportionality Analysis,” Openvigil, p 1-10, Tersedia pada: openvigil.sourceforge.net/doc/DPA.pdf